Total Revenue
Zimmer Biomet Holdings Total Revenue decreased by 7.0% to $2.09B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.3%, from $1.91B to $2.09B. Over 4 years (FY 2021 to FY 2025), Total Revenue shows an upward trend with a 4.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates growing market share or successful product adoption, while a decrease may signal competitive pressure or market contraction.
Detailed definition
Total revenue represents the gross inflow of economic benefits arising from the ordinary operating activities of the com...
Peer comparison
Standard across all public companies; peers in medical technology typically show steady, low-double-digit growth.
total_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.76B | $1.69B | $1.78B | $1.66B | $1.78B | $1.67B | $1.83B | $1.83B | $1.87B | $1.75B | $1.94B | $1.89B | $1.94B | $1.82B | $2.02B | $1.91B | $2.08B | $2B | $2.24B | $2.09B |
| QoQ Change | — | -4.4% | +5.4% | -6.4% | +7.1% | -6.3% | +9.3% | +0.3% | +2.1% | -6.2% | +10.6% | -2.6% | +2.8% | -6.1% | +10.9% | -5.6% | +8.8% | -3.7% | +12.1% | -7.0% |
| YoY Change | — | — | — | — | +1.0% | -0.9% | +2.7% | +10.1% | +4.9% | +5.0% | +6.3% | +3.2% | +3.9% | +4.0% | +4.3% | +1.1% | +7.0% | +9.7% | +10.9% | +9.3% |
Product Breakdown
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Knees | $801.1M | $745.1M | $839.2M | $792.9M | $826M | $792.4M | $911.1M | $828.6M |
| SET | $469.5M | $454.2M | $489.3M | $470.5M | $550.6M | $541.5M | $587.6M | $562.2M |
| Hips | $506.5M | $481.5M | $520M | $495.8M | $536.1M | $506.2M | $555.4M | $524.1M |
| Technology And Data Bone Cement And Surgical | — | — | — | $149.9M | $164.6M | $161.3M | $189.7M | $171.8M |
| Other Product Category | $164.9M | $143.4M | — | — | — | — | — | — |
| Total | $1.94B | $1.82B | $2.02B | $1.91B | $2.08B | $2B | $2.24B | $2.09B |
Other Product Category was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.
Geographic Breakdown — US
| Segment | Q4 '21 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '25 |
|---|---|---|---|---|---|---|
| US | $1.02B | $1.08B | $1.06B | $1.07B | $1.03B | $1.11B |
| Total | $1.78B | $1.83B | $1.83B | $1.87B | $1.75B | $1.91B |
Geographic Breakdown — Americas
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Americas | $1.2B | $1.14B | $1.27B | $1.21B | $1.27B | $1.25B | $1.41B | $1.32B |
| EMEA | $432.4M | $376.2M | $437.7M | $441.7M | $467.5M | $417M | $501.3M | $489.9M |
| Asia Pacific | $310.3M | $312M | $312.5M | $260.5M | $336.1M | $330.9M | $329.4M | $272.3M |
| Total | $1.94B | $1.82B | $2.02B | $1.91B | $2.08B | $2B | $2.24B | $2.09B |
Geographic Breakdown — Non Us
| Segment | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '25 |
|---|---|---|---|---|---|
| Others Countries | $744.5M | $770.6M | $800.7M | $722.2M | $795.5M |
| Total | $1.83B | $1.83B | $1.87B | $1.75B | $1.91B |
Non Us is derived from annual filings.
Total Revenue at Other Companies
Frequently Asked Questions
- What is Zimmer Biomet Holdings's total revenue?
- Zimmer Biomet Holdings (ZBH) reported total revenue of $2.09B in Q1 2026.
- How has Zimmer Biomet Holdings's total revenue changed year-over-year?
- Zimmer Biomet Holdings's total revenue increased by 9.3% year-over-year, from $1.91B to $2.09B.
- What is the long-term trend for Zimmer Biomet Holdings's total revenue?
- Over 4 years (2021 to 2025), Zimmer Biomet Holdings's total revenue has grown at a 4.8% compound annual growth rate (CAGR), from $6.83B to $8.23B.
- What does total revenue mean?
- The total amount of money generated from the sale of goods and services before any expenses are deducted.